SAM
IBB icon

Smartleaf Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Smartleaf Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3K Hold
49
– – ﹤0.01% 2398
2026
Q1 		$7.93K Buy
49
+48
+4,800% +$8.21K ﹤0.01% 2436
2025
Q4 		$169 Buy
+1
New +$162 ﹤0.01% 3376
2025
Q1 		– Sell
-300
Closed -$39.5K – 2930
2024
Q4 		$39.5K Hold
300
– – ﹤0.01% 1280
2024
Q3 		$43.5K Hold
300
– – 0.01% 971
2024
Q2 		$41.4K Hold
300
– – 0.01% 792
2024
Q1 		$41.3K Buy
+300
New +$41K 0.01% 719

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Smartleaf Asset Management's IBB Position: Q2 2026 in Review

Smartleaf Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 49 shares worth $9.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2398.

Smartleaf Asset Management first reported a position in IBB in Q1 2024 and has held it in 7 quarters since. The position peaked at $43.5K in Q3 2024. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Smartleaf Asset Management held 49 shares of iShares Biotechnology ETF worth $9.3K as of Q2 2026.
  • Smartleaf Asset Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2398 holding.
  • Smartleaf Asset Management first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's iShares Biotechnology ETF position peaked at $43.5K in Q3 2024.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.